Mirum Pharmaceuticals, Inc. (MIRM)
87.36
+0.79
(+0.91%)
USD |
NASDAQ |
Jan 12, 11:44
Mirum Pharmaceuticals Research and Development Expense (Quarterly): 42.90M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.492B |
| XOMA Royalty Corp. | 0.069M |
| Arcutis Biotherapeutics, Inc. | 19.60M |
| Recursion Pharmaceuticals, Inc. | 107.66M |
| Insmed, Inc. | 186.42M |